Original plan was to have all 3 phase 2 trials started in 2019. They are now all 2020. Time is money especially in the biotech space. I’d like to see remuneration linked to to outcomes not just delivered but delivered on time. A little less of the donkey vote ring-a-rounds, stopping the car to open the hood to third parties and a little more focus on organising and delivering successful trials within the timeframes specified.
Original plan was to have all 3 phase 2 trials started in 2019....
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $43.36M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $8.739K | 34.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19841 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 15.44pm 18/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |